San Diego, CA, United States of America

David E Junker



Average Co-Inventor Count = 2.1

ph-index = 9

Forward Citations = 256(Granted Patents)


Company Filing History:


Years Active: 1995-2011

Loading Chart...
Loading Chart...
20 patents (USPTO):Explore Patents

Title: Innovations by David E. Junker in GDF8 Research

Introduction: David E. Junker, based in San Diego, CA, has made significant contributions to the field of biomedicine with a remarkable portfolio of 20 patents. His work primarily focuses on the development of vaccines and treatments that address the modulation of GDF8, a protein of great interest in various biological processes.

Latest Patents: Two of his latest patents are particularly noteworthy. The first, titled "Neutralizing GDF8 epitope-based growth enhancing vaccine," presents innovative antigenic peptides derived from the GDF8 protein. This invention encompasses not only the specific peptides but also fusion proteins and antibodies capable of binding to these new peptides. These advancements promise new methods for treating animals through the modulation of GDF8 activity. The second patent, "Nucleic acids encoding neutralizing GDF8 epitope-based peptides and fusion proteins," extends this innovation into the genetic realm, providing nucleic acids that encode the antigenic peptides and their corresponding fusion proteins, further enhancing the potential for therapeutic applications.

Career Highlights: David E. Junker has honed his expertise through pivotal roles at Syntro Corporation and Schering-Plough Animal Health Corporation. His extensive experience in these organizations has facilitated his focus on developing groundbreaking solutions that leverage his patented technologies.

Collaborations: Throughout his career, Junker has collaborated with esteemed colleagues, including Mark D. Cochran and Martha A. Wild. These partnerships have been instrumental in advancing his research and driving innovation in the domain of GDF8.

Conclusion: David E. Junker’s contributions to the field of biomedical research reflect a commitment to innovative solutions that target the complexities of GDF8. With numerous patents to his name, his work continues to influence the landscape of veterinary medicine and treatment approaches. His ongoing research holds promise for future therapeutic developments that could greatly benefit animal health and welfare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…